Please remember that the value of an investment and the income from it can go down as well as up and you may get back less than you invested.
We don't provide advice so if you are in any doubt about making your own investment decisions we recommend you seek advice from a suitably qualified financial adviser.
Welcome to the Halifax marketwatch. Use our range of tools and up to date market research to find out what is happening and where. Please note that unless otherwise stated the information contained within the Halifax marketwatch Research Centre is provided by Digital Look Ltd.
Friday 24 Mar 2017
(ShareCast News) - Advanced clinical stage biopharmaceutical company PureTech Health announced a licensing and equity agreement with Novartis on Friday, intended to advance two clinical-stage programmes targeting the mechanistic target of 'rapamycin complex 1 (mTORC1) pathway'.
|Name||Value Today||Change||Change %|
|FTSE Small Cap||5379||12.83||0.24|
|FTSE AIM All-Share||918||0.29||0.03|
|FTSE AIM 50||5046||-0.23||-0.00|
|FTSE AIM 100||4474||-0.51||-0.01|
|Dow Jones I.A.||20597||-59.86||-0.29|
Monitor your chosen stocks with a watchlist.
|Hastings Group Holdings||270.00p||+2.66|
|Euromoney Institutional Investor||1,049.00p||+2.14|
Our education centre is full of
useful guides, virtual online tours and lots of FAQs to get you started.